Home

Transforming fertility treatment
with precision medicine

VivoPlex is a leader in real time and accurate intra-uterine monitoring

for the optimisation of fertility treatment and uterine health. Its product is in development as the first insertable wireless device for the measurement of key uterine parameters in vivo.

In IVF culture, parameters such as oxygen concentration, pH and temperature are set to mimic uterine levels in order to optimise embryo development and implantation.

Better understanding of these levels in humans in real time and over the long term should enable improvement of the success rate of fertility treatment, currently 25-30%.

With the increased insight into uterine physiology provided by VivoPlex’s product, key opinion leaders believe it could become a gold-standard test in fertility clinics.

Around 12% of women wishing to have a child are infertile. The IVF market is growing at a CAGR of 11% (Allied Market Research 2017), driven by factors such as rising age at which women are having children and increasing disposable income globally.

Use of the VivoPlex product in their fertility treatment should increase patients’ understanding of what is happening in their body and reduce the stress of treatment.

You can download the company presentation here.

VivoPlex’s product video here.

“Oxygen, pH and temperature are amongst the master regulators of embryonic development and implantation. Hence being able to monitor these key physiological parameters is of utmost significance when it comes to determining the suitability of the environment within the female reproductive tract. The sensor technology developed by VivoPlex will also be invaluable in ensuring that the IVF laboratory is functioning optimally.”

Professor David K Gardner, FAA

Redmond Barry Distinguished Professor, Head, Reproductive Biology and ART Laboratories, School of BioSciences, The University of Melbourne Scientific Director Melbourne IVF part of Virtus Group

“Oxygen, pH and temperature are amongst the master regulators of embryonic development and implantation. Hence being able to monitor these key physiological parameters is of utmost significance when it comes to determining the suitability of the environment within the female reproductive tract. The sensor technology developed by VivoPlex will also be invaluable in ensuring that the IVF laboratory is functioning optimally.”

Professor David K Gardner, FAA

Redmond Barry Distinguished Professor, Head, Reproductive Biology and ART Laboratories, School of BioSciences, The University of Melbourne Scientific Director Melbourne IVF part of Virtus Group

The VivoPlex product has the potential to transform the success of fertility treatment.

Partners

CONTACT US

+44 (0)2380 111 555
enquiries@vivoplex.com
University of Southampton
Science Park, Southampton
SO16 7NP, United Kingdom

SOCIAL

INFORMATION

Copyright © VivoPlex Ltd.